Scarica l'app Stockscreener
1.64
1.20%
-0.02
Dopo l'orario di chiusura:
1.67
0.03
+1.83%
Metavia Inc Borsa (MTVA) Ultime notizie
How MetaVia Inc. stock performs in stagflationJuly 2025 Summary & Growth Focused Entry Point Reports - mfd.ru
MetaVia secures patent protection for obesity treatment through 2041 - Investing.com India
MetaVia secures patent protection for obesity treatment through 2041 By Investing.com - Investing.com Nigeria
Metavia builds comprehensive global patent protection for DA-1726, securing exclusive rights to novel obesity and metabolic therapy - marketscreener.com
Can MetaVia Inc. continue delivering strong returnsMarket Movers & Entry Point Confirmation Signals - mfd.ru
MetaVia Builds Comprehensive Global Patent Protection for DA-1726, Securing Exclusive Rights to Novel Obesity and Metabolic Therapy Through 2041 - PR Newswire
Will MetaVia Inc. outperform its industry peers2025 Historical Comparison & Fast Entry and Exit Trade Plans - mfd.ru
Will MetaVia Inc. stock go up in YEAROil Prices & Real-Time Volume Surge Alerts - mfd.ru
Earnings Recap: What analysts say about MetaVia Inc. stockWeekly Investment Report & Fast Gaining Stock Strategy Reports - mfd.ru
MetaVia (MTVA) Stock Price, News & Analysis - MarketBeat
Aug Drivers: Does MetaVia Inc outperform in volatile markets2025 Big Picture & Fast Momentum Entry Tips - baoquankhu1.vn
Technical Analysis: Is now the right time to enter MetaVia IncJuly 2025 Earnings & Real-Time Buy Signal Alerts - baoquankhu1.vn
AI modeling confirms therapeutic targets for MetaVia’s vanoglipel By Investing.com - Investing.com Australia
Metavia Inc announces positive AI-modeling results from ongoing SyntekaBio collaboration, confirming key therapeutic targets for Vanoglipel - marketscreener.com
AI modeling confirms therapeutic targets for MetaVia’s vanoglipel - Investing.com
Metavia IncAnnounces Positive Ai-Modeling Results From Ongoing Syntekabio Collaboration, Confirming Key Therapeutic Targets For Vanoglipel - TradingView
MetaVia Announces Positive AI-Modeling Results from its Ongoing Syntekabio Collaboration, Confirming Key Therapeutic Targets for Vanoglipel - ChartMill
Bear Alert: Is REVBW a potential multi baggerWall Street Watch & Momentum Based Trading Signals - baoquankhu1.vn
Breakout Watch: Is MetaVia Inc in a consolidation phase2025 Trading Recap & AI Forecasted Entry and Exit Points - baoquankhu1.vn
Aug EndMonth: How correlated is RNAC to the S P500July 2025 Weekly Recap & Daily Stock Trend Reports - baoquankhu1.vn
MetaVia Updates 2025 Executive Discretionary Bonus Disclosure - TipRanks
Gainers Report: What is the next catalyst for MetaVia IncWatch List & Safe Swing Trade Setup Alerts - baoquankhu1.vn
Aug Selloffs: Will MetaVia Inc benefit from seasonalityWeekly Stock Report & Weekly High Momentum Picks - baoquankhu1.vn
Market Outlook: What is the PEG ratio of MetaVia Inc2025 Short Interest & Community Verified Watchlist Alerts - baoquankhu1.vn
Aug PreEarnings: What are analysts’ price targets for SLND.WS2025 Trading Volume Trends & Fast Gain Swing Alerts - baoquankhu1.vn
Aug Decliners: Can MetaVia Inc continue delivering strong returns2025 Risk Factors & Expert Approved Momentum Trade Ideas - baoquankhu1.vn
MTVA Stock Price, Forecast & Analysis | METAVIA INC (NASDAQ:MTVA) - Chartmill
MTVA: Positive Results for 48 mg Cohort in Phase 1b Trial of DA-1726… - Yahoo Finance
Trade Report: Can MetaVia Inc stock outperform in a bear marketJuly 2025 Rallies & Weekly Market Pulse Alerts - baoquankhu1.vn
What Does the Market Think About MetaVia Inc? - Sahm
MetaVia (NASDAQ:MTVA) Upgraded by Wall Street Zen to “Hold” Rating - Defense World
Aug Reactions: Is SWKH impacted by rising rates2025 Support & Resistance & Momentum Based Trading Ideas - baoquankhu1.vn
Aug Update: Does MetaVia Inc have strong fundamentalsPortfolio Gains Report & Free Real-Time Volume Trigger Notifications - baoquankhu1.vn
MetaVia closes $9.3 million public offering with full exercise of option - Investing.com Nigeria
MetaVia prices $8.1M underwritten public offering - MSN
MetaVia Completes Public Offering to Advance Obesity Drug - TipRanks
MetaVia closes $9.3 million public offering with full exercise of option By Investing.com - Investing.com South Africa
MetaVia Signs Multiple Material Agreements - TradingView
MetaVia Announces the Closing of $9.3 Million Underwritten Public Offering, Including Full Exercise of Allotment Option - PR Newswire
Stop Loss: What is the target price for MetaVia Inc stockTrend Reversal & Free High Accuracy Swing Entry Alerts - baoquankhu1.vn
MetaVia prices $8.1 million public offering to fund obesity treatment By Investing.com - Investing.com Nigeria
MetaVia Stock Slides After Pricing Public Offering - Nasdaq
MetaVia Inc. Prices Public Offering, Raising $8.1 Million - Intellectia AI
MetaVia prices $8.1 million public offering to fund obesity treatment - Investing.com
U.S. farmers grow wary as Ag Economy Barometer falls to 100 in August 2024 - Stock Titan
Rally Mode: Is MetaVia Inc stock showing strong momentumWeekly Trade Report & Intraday High Probability Setup Alerts - baoquankhu1.vn
Aug Retail: What catalysts could drive MetaVia Inc stock higherLayoff News & Real-Time Price Movement Reports - Bộ Nội Vụ
MetaVia’s DA-1726 shows early promise in obesity treatment - Longevity.Technology
What risks investors should watch in MetaVia Inc. stock2025 Price Targets & Entry and Exit Point Strategies - Улправда
Research Analysts Issue Forecasts for MetaVia Q4 Earnings - Defense World
VIX Spike: Why retail investors favor MetaVia Inc stock2025 Winners & Losers & Low Risk High Reward Ideas - moha.gov.vn
1.12%
0.87%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):